CMMB
Chemomab Therapeutics Ltd DRC
NASDAQ: CMMB · HEALTHCARE · BIOTECHNOLOGY
$1.47
+0.68% today
Updated 2026-04-30
Market cap
$11.59M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.44
Dividend yield
—
52W range
$1 – $6
Volume
0.1M
Chemomab Therapeutics Ltd DRC (CMMB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | $47421.00 | $44115.00 | $8856.00 | $3.50M | $27576.00 | $23622.00 | $19799.00 | $26253.00 | $40638.00 | $51000.00 | $66000.00 | $281000.00 | $79999.00 | $34023.00 | $57773.00 | $66827.00 | $53251.00 | $70555.00 |
| Gross profit | $-47421.00 | $-44115.00 | $-8856.00 | $-3.50M | — | $-23622.00 | $-19799.00 | $-26253.00 | $-40638.00 | $-51000.00 | $-66000.00 | $-281000.00 | $-79999.00 | $-34023.00 | $-57773.00 | $-66827.00 | $-53251.00 | $-70555.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $2.72M | $2.02M | $487664.00 | — | $15.72M | $3.99M | $4.90M | $5.96M | $2.34M | $6.23M | $7.56M | $13.30M | $4.68M | $6.33M | $16.98M | $18.38M | $11327.00 | $5.88M |
| SG&A | — | — | — | — | $5.65M | — | — | — | — | $3.27M | $5.49M | $6.25M | $1.29M | $6.03M | $11.56M | $7.08M | $3412.00 | $3.73M |
| Operating income | $-4.65M | $-3.48M | $-1.01M | $-5.44M | $24.18M | $-5.29M | $-6.10M | $-7.13M | $-4.63M | $-9.39M | $12.66M | $27.12M | $-5.97M | $-12.37M | $-28.53M | $-25.46M | $-14.74M | $-9.64M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-2.92M | $-6.78M | $-429000.00 | $-4.58M | $24.18M | $-5.81M | $-5.98M | $-7.46M | $-4.57M | $-9.50M | $12.66M | $27.12M | $-5.95M | $-12.33M | $-28.48M | $-25.39M | $-13.96M | $-9.57M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-2.97M | $-6.82M | $-437856.00 | $-4.62M | $24.18M | $-5.83M | $-6.00M | $-7.49M | $-4.61M | $-9.55M | $12.66M | $27.12M | $-5.97M | $-12.37M | $-28.53M | $-25.46M | $-14.01M | $-9.64M |
| Interest expense | — | — | $145735.00 | $1.38M | — | — | — | $14156.00 | — | $5000.00 | $0.00 | $4.23M | $5999.00 | $111076.00 | $353000.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-2.97M | $-6.82M | $-584000.00 | $-5.99M | $24.18M | $-5.83M | $-6.00M | $-7.50M | $-4.73M | $-9.81M | $13.28M | $27.12M | $-5.95M | $-12.48M | $-27.65M | $-24.22M | $-13.95M | $-9.07M |
| Net income growth (YoY) | — | -129.8% | +91.4% | -925.9% | +503.7% | -124.1% | -2.9% | -25.0% | +36.9% | -107.2% | +235.4% | +104.3% | -121.9% | -109.7% | -121.6% | +12.4% | +42.4% | +35.0% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |